156 related articles for article (PubMed ID: 19348511)
41. Serous papillary cystadenocarcinoma arising from autografted ovary of the abdominal wall.
Gong W; Cheng H; Yan Q; Huang G; Luo P; Wang Z
Int J Surg Pathol; 2010 Oct; 18(5):398-400. PubMed ID: 19147508
[TBL] [Abstract][Full Text] [Related]
42. Overview of the clinical problem: facts and current issues of mucinous cystic neoplasms of the pancreas.
Jeurnink SM; Vleggaar FP; Siersema PD
Dig Liver Dis; 2008 Nov; 40(11):837-46. PubMed ID: 18499541
[TBL] [Abstract][Full Text] [Related]
43. Ovarian papillary serous tumors of low malignant potential (serous borderline tumors). A long-term follow-up study, including patients with microinvasion, lymph node metastasis, and transformation to invasive serous carcinoma.
Kennedy AW; Hart WR
Cancer; 1996 Jul; 78(2):278-86. PubMed ID: 8674004
[TBL] [Abstract][Full Text] [Related]
44. Serous papillary adenocarcinoma and adult granulosa cell tumor in the same ovary. An unusual case.
Ozbey C; Erdogan G; Pestereli HE; Simsek T; Karaveli S
APMIS; 2005 Oct; 113(10):713-5. PubMed ID: 16309432
[TBL] [Abstract][Full Text] [Related]
45. Mucinous cystadenocarcinoma of the testis: a case report.
Iuga AC; Mull J; Batra R; Miller W
Hum Pathol; 2011 Sep; 42(9):1343-7. PubMed ID: 21396680
[TBL] [Abstract][Full Text] [Related]
46. Papillary serous carcinoma of peritoneum: case study and review of the literature on the differential diagnosis of malignant peritoneal tumors.
Koutselini HA; Lazaris AC; Thomopoulou G; Papayannopoulou A; Kairi-Vasilatou E
Adv Clin Path; 2001 Jul; 5(3):99-104. PubMed ID: 11753882
[TBL] [Abstract][Full Text] [Related]
47. Pure (non-papillary) serous cystadenoma of the epididymis: a histologic and immunohistochemical study.
Pich A; Galliano D
Pathol Res Pract; 2005; 201(1):65-9. PubMed ID: 15807314
[TBL] [Abstract][Full Text] [Related]
48. Clinicopathological significance of DEK overexpression in serous ovarian tumors.
Han S; Xuan Y; Liu S; Zhang M; Jin D; Jin R; Lin Z
Pathol Int; 2009 Jul; 59(7):443-7. PubMed ID: 19563407
[TBL] [Abstract][Full Text] [Related]
49. Value of estrogen and progesterone receptor immunostaining in distinguishing between peritoneal mesotheliomas and serous carcinomas.
Ordóñez NG
Hum Pathol; 2005 Nov; 36(11):1163-7. PubMed ID: 16260268
[TBL] [Abstract][Full Text] [Related]
50. Immunohistochemical analysis of peritoneal mesothelioma and primary and secondary serous carcinoma of the peritoneum: antibodies to estrogen and progesterone receptors are useful.
Barnetson RJ; Burnett RA; Downie I; Harper CM; Roberts F
Am J Clin Pathol; 2006 Jan; 125(1):67-76. PubMed ID: 16482993
[TBL] [Abstract][Full Text] [Related]
51. A case of bilateral ovarian synchronous tumors (left ovarian serous papillary adenocarcinoma and right ovarian malignant mixed Müllerian tumor).
Song MJ; Lee CW; Seo KJ; Kim JA; Park JS; Hur SY
Eur J Gynaecol Oncol; 2011; 32(2):234-6. PubMed ID: 21614928
[TBL] [Abstract][Full Text] [Related]
52. Study of ovarian cancer management.
Gaughan E; Javaid T; Cooley S; Byrne P; Gaughan G
Ir Med J; 2006 Oct; 99(9):279-80. PubMed ID: 17144239
[TBL] [Abstract][Full Text] [Related]
53. Stage III papillary serous cystadenocarcinoma of the ovary in a 15-year-old female.
Moen MD; Cliby WA; Wilson TO
Gynecol Oncol; 1994 May; 53(2):274-6. PubMed ID: 8188094
[TBL] [Abstract][Full Text] [Related]
54. Combined ovarian serous papillary and hepatoid carcinoma.
Scurry JP; Brown RW; Jobling T
Gynecol Oncol; 1996 Oct; 63(1):138-42. PubMed ID: 8898184
[TBL] [Abstract][Full Text] [Related]
55. Minimal change disease in a patient with ovarian papillary serous carcinoma.
Ryu DR; Yoo TH; Kim YT; Jeong HJ; Cho NH; Kang SW
Gynecol Oncol; 2004 May; 93(2):554-6. PubMed ID: 15099980
[TBL] [Abstract][Full Text] [Related]
56. Papillary serous carcinoma of the peritoneum coexisting with or after endometrial carcinoma.
Altaras MM; Bernheim J; Zehavi T; Drucker L; Uziel O; Fishman A
Gynecol Oncol; 2002 Feb; 84(2):245-51. PubMed ID: 11812082
[TBL] [Abstract][Full Text] [Related]
57. A 47-year-old man with rare serous cyst adenocarcinoma of the testis.
Pourvali-Souraki Z; Zaboli E; Janbabaei G; Alizadeh-Navaei R
J Cancer Res Ther; 2022; 18(1):301-304. PubMed ID: 35381807
[TBL] [Abstract][Full Text] [Related]
58. Expression of HER2/neu, estrogen and progesterone receptors, CA 125 and CA19-9 on cancer cell membrane in patients with serous and mucinous carcinoma of the ovary.
Karaferic A; Jovanovic D; Jelic S
J BUON; 2009; 14(4):635-9. PubMed ID: 20148455
[TBL] [Abstract][Full Text] [Related]
59. Serous papillary cystadenocarcinoma in supernumerary ovary.
Nomelini RS; Oliveira LJ; Jammal MP; Adad SJ; Murta EF
J Obstet Gynaecol; 2013 Apr; 33(3):324. PubMed ID: 23550880
[No Abstract] [Full Text] [Related]
60. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
